Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18728022rdf:typepubmed:Citationlld:pubmed
pubmed-article:18728022lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18728022lifeskim:mentionsumls-concept:C0033325lld:lifeskim
pubmed-article:18728022lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:18728022lifeskim:mentionsumls-concept:C1292769lld:lifeskim
pubmed-article:18728022lifeskim:mentionsumls-concept:C0312738lld:lifeskim
pubmed-article:18728022lifeskim:mentionsumls-concept:C1261322lld:lifeskim
pubmed-article:18728022lifeskim:mentionsumls-concept:C1442161lld:lifeskim
pubmed-article:18728022lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:18728022pubmed:issue11lld:pubmed
pubmed-article:18728022pubmed:dateCreated2008-11-3lld:pubmed
pubmed-article:18728022pubmed:abstractTextIn acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia. Deletions in 9p are seen in about 9% of cases of adult acute lymphoblastic leukemia, but their prognostic impact has been controversial. Cytogenetic data from 381 patients diagnosed with B-precursor acute lymphoblastic leukemia were reviewed. Chromosomal analysis was successful in 240 cases. Of these cases, 18 (8%) had abnormalities in 9p and they were compared with patients with normal karyotypes and patients with t(9;22)/BCR-ABL. Patients with abnormalities of chromosome 9 showed significantly shorter overall survival compared with patients with normal karyotypes. In fact, overall survival was similar to that in the poor prognosis t(9;22)/BCR-ABL-positive group. Our data suggest that chromosomal abnormalities involving 9p may have a significant negative impact on survival in adult B-precursor acute lymphoblastic leukemia.lld:pubmed
pubmed-article:18728022pubmed:languageenglld:pubmed
pubmed-article:18728022pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18728022pubmed:citationSubsetIMlld:pubmed
pubmed-article:18728022pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18728022pubmed:statusMEDLINElld:pubmed
pubmed-article:18728022pubmed:monthNovlld:pubmed
pubmed-article:18728022pubmed:issn1592-8721lld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:KarlssonKarin...lld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:BernellPerPlld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:HallböökHelen...lld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:AhlgrenThomas...lld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:LinderholmMat...lld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:SmedmyrBengtBlld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:HägglundHansHlld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:AströmMariaMlld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:LazarevicVlad...lld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:HardlingMatsMlld:pubmed
pubmed-article:18728022pubmed:authorpubmed-author:NahiHarethHlld:pubmed
pubmed-article:18728022pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18728022pubmed:volume93lld:pubmed
pubmed-article:18728022pubmed:ownerNLMlld:pubmed
pubmed-article:18728022pubmed:authorsCompleteYlld:pubmed
pubmed-article:18728022pubmed:pagination1734-8lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:meshHeadingpubmed-meshheading:18728022...lld:pubmed
pubmed-article:18728022pubmed:year2008lld:pubmed
pubmed-article:18728022pubmed:articleTitleAn investigation into whether deletions in 9p reflect prognosis in adult precursor B-cell acute lymphoblastic leukemia: a multi-center study of 381 patients.lld:pubmed
pubmed-article:18728022pubmed:affiliationHaematology Centre, Karolinska University Hospital Huddinge,141 86 Stockholm, Sweden. hareth.nahi@karolinska.selld:pubmed
pubmed-article:18728022pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18728022pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18728022pubmed:publicationTypeMulticenter Studylld:pubmed